Eledon Pharmaceuticals, Inc. (ELDN) Tops Q2 EPS by 9c
Get Alerts ELDN Hot Sheet
Join SI Premium – FREE
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q2 EPS of ($0.13), $0.09 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grupo Aeroportuario (ASR) Tops Q2 EPS by 438c
- C&F Financial (CFFI) Tops Q4 EPS by 240c
- First Resource Bank (FRSB) Tops Q2 EPS by 92c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share